S. D. Slater

2.5k total citations · 1 hit paper
31 papers, 1.6k citations indexed

About

S. D. Slater is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, S. D. Slater has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Epidemiology. Recurrent topics in S. D. Slater's work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Chronic Disease Management Strategies (3 papers) and Bariatric Surgery and Outcomes (3 papers). S. D. Slater is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Chronic Disease Management Strategies (3 papers) and Bariatric Surgery and Outcomes (3 papers). S. D. Slater collaborates with scholars based in United Kingdom and United States. S. D. Slater's co-authors include Anthony J. Swerdlow, S. P. Laing, Norman Waugh, A C Burden, P. J. Bingley, Andrew D. Morris, W. Gatling, H. Keen, Zipeng Qiao and J. L. Botha and has published in prestigious journals such as Stroke, British Journal of Cancer and Diabetologia.

In The Last Decade

S. D. Slater

28 papers receiving 1.5k citations

Hit Papers

Mortality from heart disease in a cohort of 23,000 patien... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. D. Slater United Kingdom 13 962 400 353 325 241 31 1.6k
S. P. Laing United Kingdom 12 988 1.0× 423 1.1× 351 1.0× 427 1.3× 225 0.9× 15 1.6k
W. Gatling United Kingdom 21 1.2k 1.2× 281 0.7× 440 1.2× 349 1.1× 309 1.3× 38 1.9k
L. H. Kuller United States 18 498 0.5× 286 0.7× 492 1.4× 249 0.8× 133 0.6× 33 1.4k
CC Patterson United Kingdom 17 951 1.0× 765 1.9× 270 0.8× 606 1.9× 172 0.7× 30 2.0k
Stefano Tumini Italy 22 792 0.8× 522 1.3× 185 0.5× 477 1.5× 329 1.4× 71 1.7k
Gary T.C. Ko Hong Kong 25 685 0.7× 194 0.5× 172 0.5× 412 1.3× 188 0.8× 66 1.5k
M.‐A. Gall Denmark 16 1.1k 1.2× 310 0.8× 364 1.0× 490 1.5× 177 0.7× 19 1.8k
Elizabeth Greyber United States 7 1.5k 1.5× 581 1.5× 184 0.5× 266 0.8× 584 2.4× 9 2.0k
Rochelle L Chaiken United States 21 969 1.0× 389 1.0× 278 0.8× 418 1.3× 284 1.2× 28 1.8k
Donald Pearson United Kingdom 16 855 0.9× 372 0.9× 209 0.6× 446 1.4× 185 0.8× 28 1.7k

Countries citing papers authored by S. D. Slater

Since Specialization
Citations

This map shows the geographic impact of S. D. Slater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. D. Slater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. D. Slater more than expected).

Fields of papers citing papers by S. D. Slater

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. D. Slater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. D. Slater. The network helps show where S. D. Slater may publish in the future.

Co-authorship network of co-authors of S. D. Slater

This figure shows the co-authorship network connecting the top 25 collaborators of S. D. Slater. A scholar is included among the top collaborators of S. D. Slater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. D. Slater. S. D. Slater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swerdlow, Anthony J., Michael E. Jones, S. D. Slater, et al.. (2023). Cancer incidence and mortality in 23 000 patients with type 1 diabetes in the UK: Long‐term follow‐up. International Journal of Cancer. 153(3). 512–523. 8 indexed citations
2.
Slater, S. D.. (2020). If Case Reports be the Food of Knowledge, Write On: Our Cases of the Quarter. The Journal of the Royal College of Physicians of Edinburgh. 50(1). 75–79. 1 indexed citations
3.
Slater, S. D.. (2011). The discovery of thyroid replacement therapy. Part 3: A complete transformation. Journal of the Royal Society of Medicine. 104(3). 100–106. 14 indexed citations
4.
Swerdlow, Anthony J., S. P. Laing, Zipeng Qiao, et al.. (2005). Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. British Journal of Cancer. 92(11). 2070–2075. 149 indexed citations
5.
Higgins, Craig, Anthony J. Swerdlow, S. P. Laing, et al.. (2005). Birthweight and other pregnancy outcomes in a cohort of women with pre‐gestational insulin‐treated diabetes mellitus, Scotland, 1979–95. Diabetic Medicine. 22(4). 440–447. 23 indexed citations
6.
Swerdlow, Anthony J., S. P. Laing, S. D. Slater, et al.. (2004). Mortality of South Asian patients with insulin‐treated diabetes mellitus in the United Kingdom: a cohort study. Diabetic Medicine. 21(8). 845–851. 24 indexed citations
7.
Laing, S. P., Anthony J. Swerdlow, S. D. Slater, et al.. (2003). Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia. 46(6). 760–765. 547 indexed citations breakdown →
8.
Laing, S. P., Anthony J. Swerdlow, Lucy Carpenter, et al.. (2003). Mortality From Cerebrovascular Disease in a Cohort of 23 000 Patients With Insulin-Treated Diabetes. Stroke. 34(2). 418–421. 94 indexed citations
9.
Laing, S. P., Anthony J. Swerdlow, S. D. Slater, et al.. (1999). The British Diabetic Association Cohort Study, II: cause‐specific mortality in patients with insulin‐treated diabetes mellitus. Diabetic Medicine. 16(6). 466–471. 241 indexed citations
10.
Laing, S. P., Anthony J. Swerdlow, S. D. Slater, et al.. (1999). The British Diabetic Association Cohort Study, I: all‐cause mortality in patients with insulin‐treated diabetes mellitus. Diabetic Medicine. 16(6). 459–465. 328 indexed citations
11.
Slater, S. D.. (1991). The Brown Kelly-Paterson or Plummer-Vinson Syndrome: An Old Score Finally Settled. Journal of the Royal College of Physicians of London. 25(3). 257–258. 5 indexed citations
12.
13.
Slater, S. D., et al.. (1987). Failure to Diagnose the Milk-Alkali Syndrome. Scottish Medical Journal. 32(2). 56–57. 11 indexed citations
14.
McKillop, Graham, Marie Fallon, & S. D. Slater. (1986). Possible interaction between heparin and a sulphonylurea a cause of prolonged hypoglycaemia?. BMJ. 293(6554). 1073–1073. 6 indexed citations
15.
Phillips, Patricia G., et al.. (1985). Successful long‐term weight loss in Type II diabetics. Practical Diabetes International. 2(2). 20–21. 1 indexed citations
16.
Hutchinson, Sharon, C. M. Kesson, & S. D. Slater. (1983). Does diabetes affect employment prospects?. BMJ. 287(6397). 946.2–947. 13 indexed citations
17.
Slater, S. D., et al.. (1980). Treatment of Resistant Supraventricular Tachycardia with Mexiletine. International Journal of Clinical Practice. 34(8-9). 247–250. 3 indexed citations
18.
Slater, S. D.. (1974). Alloantibodies and Australia antigen after open heart surgery. Journal of Clinical Pathology. 27(1). 45–49.
19.
Slater, S. D., C. R. M. Prentice, W H Bain, & J. D. Briggs. (1973). Fibrinogen-Fibrin Degradation Product Levels in Different Types of Intravascular Haemolysis. BMJ. 3(5878). 471–473. 14 indexed citations
20.
Slater, S. D., A. G. G. Turpie, A. S. Douglas, & G. P. McNicol. (1972). Effect in vitro on platelet function of two compounds developed from the pyrimido-pyrimidines. Journal of Clinical Pathology. 25(5). 427–432. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026